About GRA Venture Fund
GRA Venture Fund is a venture capital firm founded in 2009. It is primarily based out of Atlanta, United States. As of Sep 2023, GRA Venture Fund has invested in 35 companies. It primarily invests in Seed round in United States based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to Life Sciences and High Tech. Most recently it participated in the $***** Series A round of Lucid Scientific Overall, GRA Venture Fund portfolio has seen 1 IPO and 8 acquisitions including key companies like Dragos, BioCircuit and Axion Biosystems. A lot of funds co-invest with GRA Venture Fund, with names like TechSquare Labs sharing a substantial percentage of its portfolio. GRA Venture Fund has team of 1 people including 1 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed, Series A & 3 more
Portfolio IPOs
Portfolio Acquisitions
Portfolio Soonicorns
GRA Venture Fund's List of Top Investments
GRA Venture Fund has a portfolio of 35 companies. Their most notable investments are in Pindrop Security and Carbice.Their portfolio spans across United States and Malta. They have invested in Enterprise Applications, Life Sciences, High Tech and 16 other sectors, across stages such as Seed, Series A and 3 more. Here is the list of top investments by GRA Venture Fund:Provider of voice security and authentication solutions for virtual interactions. The company delivers tools to identify fraud and deepfakes in contact centers and meetings. It offers authentication and risk assessment using voice, device, and behavioral analysis. Solutions cater to various industries, securing communications across multiple channels.
Key facts about Pindrop Security
- Founded Year: 2011
- Location: Atlanta (United States)
- Valuation: $*****
- Stage: Series D
- Total Funding till date: $232M
- Employee Count: 372 as on Sep 30, 2026
- Investors: Cross Creek, CapitalG and 40 Others
- Latest Funding Round: Venture Debt, Jul 17, 2024, $*****
- Highlight: Editors' Pick
2. Dragos
Provider of cybersecurity solutions and intelligence for industrial control systems. The company delivers a platform providing asset visibility, vulnerability management, and threat detection. Services include cyber assessments, incident response, and proactive threat hunting. The firm offers threat intelligence reports, whitepapers, and solution briefs.
Key facts about Dragos
- Founded Year: 2016
- Location: Hanover (United States)
- Last Known Valuation: $*****
- Stage: Acquired
- Total Funding till date: $439M
- Employee Count: 848 as on Sep 30, 2026
- Investors: Fabrica Ventures, BYU Cougar Capital and 29 Others
- Latest Funding Round: Series D, Sep 18, 2023, $*****
- Highlight: Acquired
3. Codoxo
AI-based platform for employee and individual healthcare planning. It analyzes claims data, detects practices that intentionally or unintentionally waste money, and builds connections across data to provide actionable insights. It analyzes all types of professional, facility, pharmacy, behavioral, dental, and workers claims.
Key facts about Codoxo
- Founded Year: 2016
- Location: Atlanta (United States)
- Stage: Series C
- Total Funding till date: $75M
- Employee Count: 97 as on Aug 31, 2026
- Investors: QED Investors, Spider Capital and 15 Others
- Latest Funding Round: Series C, Dec 17, 2025, $*****
- Highlight: Editors' Pick
Developed microneedle patch technology for vaccines and drug delivery. The patch targets skin with minimally invasive microneedle penetrates the upper layers of skin and dissolves rapidly.
Key facts about Micron Biomedical
- Founded Year: 2014
- Location: Atlanta (United States)
- Stage: Series A
- Total Funding till date: $33M
- Employee Count: 27 as on Sep 30, 2026
- Investors: Gates, GRA Venture Fund and 10 Others
- Latest Funding Round: Grant (prize money), Jan 14, 2025, $*****
- Highlight: Editors' Pick
5. BioCircuit
Developer of non-invasive electrophysiology devices to monitor peripheral nerves. The company is developed a multielectrode array-based technology that uses proprietary algorithms to test peripheral nerve activity.
Key facts about BioCircuit
- Founded Year: 2016
- Location: Atlanta (United States)
- Stage: Acquired
- Total Funding till date: $13.6M
- Employee Count: 45 as on Aug 31, 2026
- Investors: GRA Venture Fund, Masters Capital Management and 4 Others
- Latest Funding Round: Grant (prize money), Aug 28, 2025, $*****
- Highlight: Acquired
GRA Venture Fund's Year-on-Year Investment Trends
GRA Venture Fund has invested in 35 companies over the last 16 years, with an average of 1 new investment annually in the last 10 years. Its most recent first time investment was in Micron Biomedical and most recent follow-on round was in Lucid Scientific.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 0 | 0 | 0 |
2025 | 0 | 0 | 0 |
2024 | 0 | 0 | 0 |
2023 | 0 | 1 | 1 |
2022 | 3 | 1 | 4 |
2021 | 0 | 1 | 1 |
2020 | 2 | 1 | 3 |
2019 | 0 | 0 | 0 |
2018 | 1 | 1 | 2 |
2017 | 4 | 1 | 5 |
GRA Venture Fund's Investments by Stage
GRA Venture Fund has made 8 investments in Seed stage with an average round size of $1.59M, 6 investments in Series A stage with an average round size of $13.4M, 3 investments in Series B stage with an average round size of $9.29M, 2 investments in Series C stage with an average round size of $9M and 1 investment in Series D stage with an average round size of $40M.Stage of entry | No. of Investments |
|---|---|
Seed | 8 |
Series A | 6 |
Series B | 3 |
Series C | 2 |
Series D | 1 |
Note: We have considered here, only first round of investments
GRA Venture Fund's Investments by Sector
GRA Venture Fund has a diverse portfolio, with companies operating in the Enterprise Applications, Life Sciences, High Tech, Enterprise Infrastructure and Environment Tech. Notably, it has invested in 31 Tech companies, 29 Enterprise (B2B) companies, 19 Software companies and at least 8 companies focusing on Tech hardware.Sector | No. of Investments |
|---|---|
Enterprise Applications | 7 |
Life Sciences | 7 |
High Tech | 4 |
Enterprise Infrastructure | 3 |
Environment Tech | 3 |
Others | 16 |
Note: We have considered here, only first round of investments
GRA Venture Fund's Investments by Geography
GRA Venture Fund has made most investments in United States (20).GRA Venture Fund's recent investments
GRA Venture Fund has not made any investment in 2026 so far.Here are the most recent investments by GRA Venture Fund:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Sep 05, 2023 | United States | Series A | 6840 | [+1] | |
Nov 28, 2022 | United States | Series A | 6377 | [+5] | |
Nov 18, 2022 | United States | Series A | 4375 | [+2] | |
Sep 27, 2022 | United States | Series B | 8465 | ||
Feb 03, 2022 | United States | Series B | 8563 | [+4] |
IPOs and Publicly Listed companies in GRA Venture Fund's Portfolio
1 of GRA Venture Fund's portfolio company became public - Clearside Biomedical. It got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Jun 2016 at marketcap of $137MHere are GRA Venture Fund's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jun 02, 2016 | Sep 02, 2014 | Series B | 7266 |
Acquired companies in GRA Venture Fund's Portfolio
8 companies from GRA Venture Fund's portfolio have been acquired. The most recent acquisition was BioCircuit in Sep 2026 by AxoGen for $*****.Here are GRA Venture Fund's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Sep 10, 2026 | Sep 27, 2022 | Series B | 4945 | |
Jun 18, 2026 | - | - | 8342 | |
May 24, 2022 | Aug 02, 2011 | Series A | 6604 | |
Jul 15, 2021 | May 16, 2016 | Series C | 2385 | |
Mar 18, 2019 | - | - | 7130 |
Team profile of GRA Venture Fund
GRA Venture Fund has a team of 1 member located in United States. GRA Venture Fund's team does not sit on the board of any company as of now.Co-investors of GRA Venture Fund
Over the past 16 years, 123 investors have co-invested in GRA Venture Fund's portfolio companies. This includes funds and angels.
- Invested before GRA Venture Fund: National Science Foundation, HHS and 11 others have invested in rounds before GRA Venture Fund. There are 2 companies where National Science Foundation has invested before GRA Venture Fund and 2 companies where HHS has invested before GRA Venture Fund.
- Top Co-investors of GRA Venture Fund: 43 investors entered a company along with GRA Venture Fund. These include investors like TechSquare Labs (2 companies).
- Invested after GRA Venture Fund: A total of 67 investors have invested in GRA Venture Fund's portfolio after their investments. Top Investors include Felicis Ventures (1 company), Citi Ventures (1 company) and Redpoint Ventures (1 company).
Recent News related to GRA Venture Fund
•
Lucid Scientific Secures $7 Million in Series A Funding, Led by IAG Capital PartnersSilicon Valley Journals•Sep 27, 2023•Lucid Scientific, IAG Capital Partners, GRA Venture Fund, Dynamk Capital and 1 other
•
USA-based Micron Biomedical raises an additional USD 3 million in Series AVcbay News•May 11, 2023•Micron Biomedical, J2 Ventures, Global Health Investment, LTS Lohmann and 3 others
•
Micron Biomedical Secures USD14M in Series A FinancingFinSMEs•Nov 29, 2022•Micron Biomedical, Global Health Investment, LTS Lohmann, GRA Venture Fund
•
Nyra Medical Raises $20M in Series A FinancingFinSMEs•Nov 24, 2022•Nyra Medical, Vensana Capital, Epidarex Capital, GRA Venture Fund and 2 others
•
BioCircuit Technologies Closes $9 Million Series Seed RoundMedical Product Outsourcing•Nov 04, 2022•BioCircuit, GRA Venture Fund, Masters Capital Management
•
Atlanta Medical Device Startup BioCircuit Technologies Raises $9 MillionMetro Atlanta CEO•Oct 05, 2022•BioCircuit, Masters Capital Management, GRA Venture Fund
•
BioCircuit Technologies, Inc. Closes a $9 million Series Seed RoundGlobeNewswire•Sep 27, 2022•BioCircuit, Masters Capital Management, GRA Venture Fund
•
Antios Therapeutics Raises $75 Million in a Series B-1 Funding to Advance Clinical Programs for HBVAntios Therapeutics•Nov 03, 2021•Antios Therapeutics, GordonMD Global Investments, EPIQ, Avego and 15 others
•
FraudScope Raises $7 Million in Series A Funding to Expand its AI Solutions to Address Healthcare Fraud, Waste & AbusePRWeb•Jul 02, 2020•Fraudscope, QED Investors, Brewer Lane Ventures, GRA Venture Fund and 4 others
•
Apptega Expands Cybersecurity Management & Compliance Growth with New Funding from GRA Venture FundApptega•Jun 30, 2020•Apptega, The Circadian Group, Ascent Capital, TiE Angels and 1 other
